中文版 | English
题名

A Novel Caffeoylquinic Acid from Lonicera japonica Exerts Cytotoxic Activity by Blocking the YAP-CTGF Signaling Pathway in Hepatocellular Carcinoma

作者
通讯作者Ge, Lanlan; Yao, Jie; Zeng, Xiaobin; Tang, Xudong
发表日期
2023-05-01
DOI
发表期刊
ISSN
0102-695X
EISSN
1981-528X
卷号33期号:4
摘要
We have purified a novel caffeoylquinic acid named 3,4-di-O-caffeoylquinic acid isobutyl ester from the flower buds of Lonicera japonica Thunb., Caprifoliaceae. However, the biological function of 3,4-di-O-caffeoylquinic acid isobutyl ester is still unknown. Here, we found that 3,4-di-O-caffeoylquinic acid isobutyl ester effectively inhibited the proliferation and migration of hepatocellular carcinoma cells, and it displayed less toxicity to a normal liver cell line. Mechanistic studies showed that 3,4-di-O-caffeoylquinic acid isobutyl ester diminished the expression of YAP at the mRNA level. Overexpression of YAP significantly rescued HepG2 cells from the 3,4-di-O-caffeoylquinic acid isobutyl ester-induced suppression of proliferation and migration. Furthermore, the YAP downstream target gene CTGF was significantly repressed upon 3,4-di-O-caffeoylquinic acid isobutyl ester treatment, which was ameliorated by YAP overexpression. In addition, 3,4-di-O-caffeoylquinic acid isobutyl ester decreased the expression of ss-catenin as well as CDK4/6. Collectively, 3,4-di-O-caffeoylquinic acid isobutyl ester exerts antihepatocellular carcinoma activity by inhibiting the YAP-CTGF pathway which controls the proliferation and migration of hepatocellular carcinoma cells. The Wnt/ss-catenin pathway might be another pathway by which 3,4-di-O-caffeoylquinic acid isobutyl ester exerts antihepatocellular carcinoma activity. As a novel natural compound, 3,4-di-O-caffeoylquinic acid isobutyl ester might be a promising agent for hepatocellular carcinoma therapy.
关键词
相关链接[来源记录]
收录类别
语种
英语
学校署名
通讯
资助项目
National Natural Science Foundation of China["81903760","82204682"] ; Guangdong Basic and Applied Basic Research[2021A1515110841] ; Shenzhen Science and Technology Program["JCYJ20210324113003007","JCYJ20190806151816859"]
WOS研究方向
Pharmacology & Pharmacy
WOS类目
Chemistry, Medicinal ; Pharmacology & Pharmacy
WOS记录号
WOS:001000199100001
出版者
来源库
Web of Science
引用统计
被引频次[WOS]:2
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/549062
专题南方科技大学第一附属医院
作者单位
1.Gansu Univ Chinese Med, Coll Pharm, Lanzhou, Peoples R China
2.Jinan Univ, Shenzhen Peoples Hosp, Ctr Lab Longhua Branch, Dept Infect Dis,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
3.Southern Univ Sci & Technol, Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
4.Res Inst Tsinghua Univ, Key Lab Innovat Tradit Chinese Med & Nat Med, Shenzhen, Guangdong, Peoples R China
5.Jinan Univ, Ctr Lab Longhua Branch, Dept Infect Dis,Shenzhen Peoples Hosp, 2nd Clin Med Coll, Shenzhen, Guangdong, Peoples R China
第一作者单位南方科技大学第一附属医院
通讯作者单位南方科技大学第一附属医院
推荐引用方式
GB/T 7714
Shen, Wanying,Wei, Xiaofang,Li, Yangfang,et al. A Novel Caffeoylquinic Acid from Lonicera japonica Exerts Cytotoxic Activity by Blocking the YAP-CTGF Signaling Pathway in Hepatocellular Carcinoma[J]. REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY,2023,33(4).
APA
Shen, Wanying.,Wei, Xiaofang.,Li, Yangfang.,Liu, Chenxiao.,Ge, Lanlan.,...&Tang, Xudong.(2023).A Novel Caffeoylquinic Acid from Lonicera japonica Exerts Cytotoxic Activity by Blocking the YAP-CTGF Signaling Pathway in Hepatocellular Carcinoma.REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY,33(4).
MLA
Shen, Wanying,et al."A Novel Caffeoylquinic Acid from Lonicera japonica Exerts Cytotoxic Activity by Blocking the YAP-CTGF Signaling Pathway in Hepatocellular Carcinoma".REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY 33.4(2023).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Shen, Wanying]的文章
[Wei, Xiaofang]的文章
[Li, Yangfang]的文章
百度学术
百度学术中相似的文章
[Shen, Wanying]的文章
[Wei, Xiaofang]的文章
[Li, Yangfang]的文章
必应学术
必应学术中相似的文章
[Shen, Wanying]的文章
[Wei, Xiaofang]的文章
[Li, Yangfang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。